Muromonab-CD3 (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Muromonab-CD3" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
4th place
7th place
2nd place
2nd place
1st place
1st place
low place
6,443rd place
low place
low place
399th place
214th place
low place
low place

doi.org

  • Midtvedt K, Fauchald P, Lien B, và đồng nghiệp (tháng 2 năm 2003). “Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection”. Clinical Transplantation. 17 (1): 69–74. doi:10.1034/j.1399-0012.2003.02105.x. PMID 12588325.
  • Smith, S. L. (1996). “Ten years of Orthoclone OKT3 (muromonab-CD3): a review”. Journal of Transplant Coordination. 6 (3): 109–119, quiz 119–1. doi:10.7182/prtr.1.6.3.8145l3u185493182. PMID 9188368.
  • Abramowicz, D.; Schandene, L.; Goldman, M.; Crusiaux, A.; Vereerstraeten, P.; De Pauw, L.; Wybran, J.; Kinnaert, P.; Dupont, E. (1989). “Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients”. Transplantation. 47 (4): 606–608. doi:10.1097/00007890-198904000-00008. PMID 2523100.

drugs.com

genengnews.com

guidetopharmacology.org

  • “muromonab-CD3”. Guide to Pharmacology. IUPHAR/BPS. Truy cập ngày 21 tháng 8 năm 2015.

nephrologyrounds.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Midtvedt K, Fauchald P, Lien B, và đồng nghiệp (tháng 2 năm 2003). “Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection”. Clinical Transplantation. 17 (1): 69–74. doi:10.1034/j.1399-0012.2003.02105.x. PMID 12588325.
  • Smith, S. L. (1996). “Ten years of Orthoclone OKT3 (muromonab-CD3): a review”. Journal of Transplant Coordination. 6 (3): 109–119, quiz 119–1. doi:10.7182/prtr.1.6.3.8145l3u185493182. PMID 9188368.
  • Gramatzki M, Burger R, Strobel G, và đồng nghiệp (tháng 3 năm 1995). “Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness”. Leukemia. 9 (3): 382–90. PMID 7885036.
  • Abramowicz, D.; Schandene, L.; Goldman, M.; Crusiaux, A.; Vereerstraeten, P.; De Pauw, L.; Wybran, J.; Kinnaert, P.; Dupont, E. (1989). “Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients”. Transplantation. 47 (4): 606–608. doi:10.1097/00007890-198904000-00008. PMID 2523100.

web.archive.org